Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
pharmacology, toxicology and pharmaceutics
Novel metabolites of amodiaquine formed by CYP1A1 and CYP1B1: Structure elucidation using electrochemistry, mass spectrometry, and NMR
Drug Metabolism and Disposition, Volume 37, No. 3, Year 2009
Notification
URL copied to clipboard!
Description
An aldehyde metabolite of amodiaquine and desethylamodiaquine has been identified. The aldehyde was the major metabolite formed in incubations with two recombinantly expressed human cytochromes P450 (rP450s), namely, CYP1A1 and CYP1B1. The aldehyde metabolite was also formed, to a lesser extent, in both human and rat liver microsomes. When comparing results from incubations with liver microsomes from 3-methylcholanthrenetreated rats (inducing CYP1A1 and CYP1B1) with those from non-induced rats, a 6-fold increase of the aldehyde metabolite was observed in the rat liver microsomes after 3-methylcholanthrene treatment. The metabolic oxidation was mimicked by the electrochemical system, and the electrochemical oxidation product was matched with the metabolite from the in vitro incubations. The electrochemical generation of the aldehyde metabolite was repeated on a preparative scale, and the proposed structure was confirmed by NMR. Trapping of the aldehyde metabolite was done with methoxyl amine. Trapping experiments with N-acetyl cysteine revealed that the aldehyde was further oxidized to an aldehyde quinoneimine species, both in the rP450 incubations and in the electrochemical system. Three additional new metabolites of amodiaquine and desethylamodiaquine were formed via rCYP1A1 and rCYP1B1. Trace amounts of these metabolites were also observed in incubations with liver microsomes from 3-methylcholanthrenetreated rats. Tentative structures of the metabolites and adducts were assigned based on liquid chromatography/tandem mass spectrometry in combination with accurate mass measurements. Copyright © 2009 by The American Society for Pharmacology and Experimental Therapeutics.
Authors & Co-Authors
Johansson, Tove
Sweden, Sodertalje
Astrazeneca Sweden
Sweden, Gothenburg
Göteborgs Universitet
Jurva, Ulrik
Sweden, Sodertalje
Astrazeneca Sweden
Gron̈berg, Gunnar
Sweden, Sodertalje
Astrazeneca Sweden
Weidolf, L. O.G.
Sweden, Sodertalje
Astrazeneca Sweden
Masimirembwa, Collen Mutowembwa
Zimbabwe, Harare
African Institute of Biomedical Science and Technology
Statistics
Citations: 74
Authors: 5
Affiliations: 3
Identifiers
Doi:
10.1124/dmd.108.025171
ISSN:
00909556
e-ISSN:
1521009X
Research Areas
Noncommunicable Diseases